Anthony S. Gibney - 13 May 2025 Form 3 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Financial and Business Officer. Exhibit 24.1 - Power of Attorney.
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Issuer symbol
AURA
Transactions as of
13 May 2025
Net transactions value
$0
Form type
3
Filing time
16 May 2025, 16:55:54 UTC
Previous filing
21 Jun 2024
Next filing
20 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gibney Anthony S Chief Financial and Business Officer. Exhibit 24.1 - Power of Attorney. C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON /s/ Conor Kilroy, as Attorney-in-Fact 16 May 2025 0001750132

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AURA Common Stock 8,452 13 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AURA Stock Option (Right to Buy) 13 May 2025 Common Stock 5,000 $7.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in three substantially equal monthly installments beginning on April 3, 2025, subject to the Reporting Person's continued service as of each such vesting date.

Remarks:

Chief Financial and Business Officer. Exhibit 24.1 - Power of Attorney.